Wedge Capital Management L L P Rvl Pharmaceuticals PLC Transaction History

Wedge Capital Management L L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 14, 2021	SELL	$2.8 - $3.78 $957,860 - $1.29 Million	-342,093 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$3.26 - $4.84 $1,281 - $1,902	393 Added 0.12%	342,093 $1.12 Million
Q4 2020 Jan 08, 2021	BUY	$4.12 - $6.29 $913,276 - $1.39 Million	221,669 Added 184.68%	341,700 $1.41 Million
Q2 2020 Jul 10, 2020	SELL	$2.83 - $6.99 $519,483 - $1.28 Million	-183,563 Reduced 60.46%	120,031 $808,000
Q1 2020 Apr 13, 2020	BUY	$3.18 - $7.0 $318,696 - $701,533	100,219 Added 49.28%	303,594 $965,000
Q4 2019 Jan 15, 2020	BUY	$3.46 - $7.7 $331,993 - $738,830	95,952 Added 89.32%	203,375 $1.42 Million
Q3 2019 Nov 01, 2019	BUY	$2.8 - $3.99 $300,784 - $428,617	107,423 New	107,423 $413,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

Stay updated on Wedge Capital Management L L P with notifications on news.